UPMC to Build $300M Center for 'Innovative' Biomedical Science | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of Pittsburgh Medical Center said today that it plans to invest $294 million in building a research center in Pittsburgh that will focus on personalized medicine and the biology of cancer and aging.

The 350,000-square-foot Center for Innovative Science will be located at the site of the former Ford Motor Co. Building on Centre Ave., which UPMC bought in 2007, and will support 375 new scientific and administrative jobs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Dec
08
Sponsored by
Personal Genome Diagnostics

This online seminar will discuss the application of circulating tumor DNA (ctDNA) sequencing to evaluate the emergence of resistance mutations during therapy.